title: Corporate coalitions and policy making in the European Union: how and why British American Tobacco promoted "Better Regulation".
abstract: Over the past fifteen years, an interconnected set of regulatory reforms, known as Better Regulation, has been adopted across Europe, marking a significant shift in the way that European Union policies are developed. There has been little exploration of the origins of these reforms, which include mandatory ex ante impact assessment. Drawing on documentary and interview data, this article discusses how and why large corporations, notably British American Tobacco (BAT), worked to influence and promote these reforms. Our analysis highlights (1) how policy entrepreneurs with sufficient resources (such as large corporations) can shape the membership and direction of advocacy coalitions; (2) the extent to which "think tanks" may be prepared to lobby on behalf of commercial clients; and (3) why regulated industries (including tobacco) may favor the use of "evidence tools," such as impact assessments, in policy making. We argue that a key aspect of BAT's ability to shape regulatory reform involved the deliberate construction of a vaguely defined idea that could be strategically adapted to appeal to diverse constituencies. We discuss the theoretical implications of this finding for the Advocacy Coalition Framework, as well as the practical implications of the findings for efforts to promote transparency and public health in the European Union.
authors: University of Edinburgh.
authors: Katherine Elizabeth
authors: KE
authors: Smith
authors: Aston University.
authors: Gary
authors: G
authors: Fooks
authors: University of Bath.
authors: Anna B
authors: AB
authors: Gilmore
authors: Jeff
authors: J
authors: Collin
authors: University of Edinburgh.
authors: Heide
authors: H
authors: Weishaar
mesh_terms: D003299:Cooperative Behavior; D005062:European Union; D033161:Government Regulation; D006291:Health Policy; D006801:Humans; D008119:Lobbying; D011050:Policy Making; D011634:Public Health; D019460:Tobacco Industry / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D006113:United Kingdom
keywords: European Union; ideational theory; public health policy; regulatory reform; think tanks
references: Tob Control. 2001 Dec;10(4):375-82
references: 11740031
references: J Public Health Policy. 2008 Apr;29(1):86-104; discussion 105
references: 18368021
references: Regulation. 1981 Jan-Feb;5(1):33-40
references: 10309353
references: J Epidemiol Community Health. 2004 Jul;58(7):546-51
references: 15194713
references: J Epidemiol Community Health. 2002 Aug;56(8):611-6
references: 12118053
references: Lancet. 2008 Sep 6;372(9641):860-1
references: 18774419
references: Lancet. 2013 Mar 30;381(9872):1125-34
references: 23541053
references: J Bus Ethics. 2013 Jan;112(2):283-299
references: 23997379
references: Public Health. 2009 Apr;123(4):306-10
references: 19324380
references: Health Econ Policy Law. 2006 Jul;1(Pt 3):203-7
references: 18634693
references: J Epidemiol Community Health. 2003 Sep;57(9):659-62
references: 12933768
references: Eur J Public Health. 2010 Apr;20(2):176-81
references: 19549801
references: J Epidemiol Community Health. 2010 Jun;64(6):478-87
references: 20466716
references: Int J Occup Med Environ Health. 2004;17(1):43-6
references: 15212205
references: Public Health. 2005 Dec;119(12):1122-9
references: 16329170
references: Cent Afr J Med. 1962 Jun;8:234-6
references: 13891004
references: BMJ. 2012 Oct 23;345:e7155
references: 23093025
references: Milbank Q. 2009 Mar;87(1):259-94
references: 19298423
references: Regul Toxicol Pharmacol. 2006 Feb;44(1):4-13
references: 16266777
references: Am J Prev Med. 2004 Feb;26(2):167-77
references: 14751332
references: Bull World Health Organ. 2005 Jun;83(6):472-7
references: 15976899
references: Am J Public Health. 2001 Nov;91(11):1749-57
references: 11684593
references: J Public Health Med. 2003 Jun;25(2):107-12
references: 12848398